Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nucore Medical is a private medical device company focused on technologies for the detection and intervention of early-stage lung cancer. Available public information indicates that it operates as a wholly owned subsidiary of Prana Thoracic, which rebranded to Prana Surgical in January 2025. Nucore Medical has been associated with development and commercialization efforts around a minimally invasive, image-guided lung tissue excision system intended to help physicians localize and excise suspicious lung tissue while preserving healthy tissue. The company has received grant support from the Cancer Prevention and Research Institute of Texas. Public disclosures on Nucore Medical itself are limited, and much of the operational and product information appears to be communicated through its parent organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nucore Medical.